Skip to main content
Livermore
Livermore
ZHEN

Belpointe Asset Management LLC

SEC CIK
0001721242
Latest filing
Jul 31, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Belpointe Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
2,371
Value
$1.48M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of REGN by Belpointe Asset Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,371$1.48M<0.1%+158+7.1%AddedHolders
Q1 20262,213$1.71M0.1%−35−1.6%ReducedHolders
Q4 20252,248$1.74M0.1%+2,248NewHolders
Q2 20250$00.0%−1,011−100.0%Sold outHolders
Q1 20251,011$641.2K<0.1%−959−48.7%ReducedHolders
Q4 20241,970$2.34M0.1%+127+6.9%AddedHolders
Q3 20241,843$1.94M0.1%+54+3.0%AddedHolders
Q2 20241,789$1.88M0.1%+475+36.1%AddedHolders
Q1 20241,314$1.26M0.1%+985+299.4%AddedHolders
Q4 2023329$289.0K<0.1%−483−59.5%ReducedHolders
Q3 2023812$668.2K0.1%+439+117.7%AddedHolders
Q2 2023373$268.0K<0.1%−669−64.2%ReducedHolders
Q1 20231,042$856.2K<0.1%−61−5.5%ReducedHolders
Q4 20221,103$795.8K<0.1%−150−12.0%ReducedHolders
Q3 20221,253$863.0K0.1%+604+93.1%AddedHolders
Q2 2022649$384.0K<0.1%−4−0.6%ReducedHolders
Q1 2022653$456.0K<0.1%−1,122−63.2%ReducedHolders
Q4 20211,775$1.12M0.1%−3,525−66.5%ReducedHolders
Q3 20215,300$3.21M0.2%+2,842+115.6%AddedHolders
Q2 20212,458$1.37M0.1%−2,043−45.4%ReducedHolders
Q1 20214,501$1.93M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.